Featured patents

Mycobacterium Antigens
US 08697091 B2, April 15, 2014, Benjamin Sidders et al. / The Secretary of State for Environment, Food & Rural Affairs acting through the Animal Health and Veterinary Laboratories Agency (Worcester Worcestershire, GB)
An isolated peptide consisting of the amino acid sequence of SEQ ID NO: 9, 10…

Mycobacterium Tuberculosis Vaccine
US 08647641 B2, Feb. 11, 2014, Peter Sander et al. / University of Zurich (Zurich, CH)
A method for prophylactically immunizing a patient at risk of becoming infected…

Allelic Exchange Mutagenesis in Map
US 08784842 B2, July 22, 2014, John Dahl et al. / Washington State University (Pullman, US)
A method for directed allelic exchange mutagenesis of slow-growing…

Antibody Profiles Characteristic of Tuberculosis State
US 08722061 B2, May 13, 2014, Maria Laura Gennaro / Rutgers, The State University of New Jersey (New Brunswick, US)
A method of diagnosis of tuberculosis in a human subject, the method comprising:…

Antigens for Paratuberculosis Diagnosis and Vaccination
US 08470339 B2, June 25, 2013, Baptiste Leroy et al. / Universite de Mons (Mons, BE)
An isolated antigen of Mycobacterium avium subsp. paratuberculosis ,…

Combination Vaccines Against Mycobacterium Sp. And Methods of Using the Same
US 08465753 B2, June 18, 2013, Robert J. Greenstein
A method for producing a vaccine for immunizing a subject against…

Identification of Virulence Associated Regions RD1 and RD5 Leading to Improve Vaccine of M. Bovis BCG and M. Microti
US 08747866 B2, June 10, 2014, Caroline Demangel et al. / Institut Pasteur (Paris, FR)
A strain of M. microti , wherein said strain has integrated all or part…

In Vitro Model of Latent Mycobacterial Infection
US 08551499 B2, Oct. 8, 2013, Jaiyanth Daniel et al. / University of Central Florida Research Foundation, Inc. (Orlando, US)
An in vitro model of latent tuberculosis, the model comprising an isolated…

Method for Preventing or Treating M Tuberculosis Infection
US 08470338 B2, June 25, 2013, Steven Reed et al. / GlaxoSmithKline Biologicals, S.A. (Rixensart, BE)
A method for preventing or delaying tuberculosis reactivation in a subject,…

Mycobacterial Immunotherapy for Cancer Treatment
US 08557257 B2, Oct. 15, 2013, Donald L. Morton / Oncovac Inc. (Pacific Palisades, US)
A method for treating a malignant melanoma tumor in a subject comprising…

Mycobacterial Mutants Inducing IL-12
US 08591918 B2, Nov. 26, 2013, John Chan et al. / Albert Einstein College of Medicine of Yeshiva University (Bronx, US)
A recombinant mycobacterium comprising a deletion of a gene of a region 3…

Polypeptide Vaccine and Vaccination Strategy Against Mycobacterium
US 08741313 B2, June 3, 2014, Manl Cheruvu et al. / Emory University (Atlanta, US)
A vaccine comprising:…

Pro-Apoptotic Bacterial Vaccines to Enhance Cellular Immune Responses
US 08481056 B2, July 9, 2013, Douglas S. Kernodle et al. / Vanderbilt University (Nashville, US)
A method of modifying a bacterium to enhance the immunogenicity of the bacterium,…

Therapeutic Vaccination Against Active Tuberculosis
US 08771709 B2, July 8, 2014, Jerald Sadoff et al. / Crucell Holland B.V. (Leiden, NL)
A method of treating a patient having active tuberculosis (TB), the method…

Tuberculosis Vaccine With Improved Efficacy
US 08545854 B2, Oct. 1, 2013, Stefan H. E. Kaufmann et al. / Max-Planck-Gesellschaft zur Foerderung der Wissenshaften, e.V. (Munich, DE)
A Mycobacterium cell which is urease-deficient and which comprises…

Tuberculosis Vaccines Comprising Antigens Expressed During the Latent Infection Phase
US 08703151 B2, April 22, 2014, Claus Aagaard et al. / Statens Serum Institut (Copenhagen S, DK)
An immunogenic composition comprising a fusion polypeptide that comprises…

Vaccine Candidates Against Johne's Disease
US 08758773 B2, June 24, 2014, Adel Mohamed Talaat / Wisconsin Alumni Research Foundation (Madison, US)
A composition comprising an isolated mutant M. paratuberculosis bacterium,…

Patentorg has 17 documents under Mycobacterium Patents.

Other subcategories for category Drug, bio-affecting and body treating compositions
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot